MicrobeWorld App

appsquarebannerad200x200

Join MicrobeWorld

Subscribe via Email

subscribe

Microbes After Hours

MW-Site-Banner-200x200

Click for more "Microbes After Hours" videos

Featured Image

Featured Video

Crowdsourced Microbes Heading to Station

Supporters

ASM House 200X200

Drug Combo Cuts Malaria Risk in HIV Patients

Treatment with lopinavir/ritonavir (Kaletra) reduced the risk that HIV-infected children would become co-infected with malaria, researchers said here.

Compared with treatment based on non-nucleoside reverse transcriptase inhibitors (NNRTIs), therapy with the protease inhibitor-based combination resulted in a 41% decrease in the incidence of malaria, said Jane Achan, MD, lecturer in pediatrics at Makarere University of Health Sciences, Kampala, Uganda.

The incidence rate was 2.25 malaria cases a year among those treated with NNRTIs and 1.32 cases a year with those on the protease inhibitor (P=0.04), she reported at the Conference on Retroviruses and Opportunistic Infections.
 
 

Comments (0)

Collections (0)

 

American Society for Microbiology
2012 1752 N Street, N.W. • Washington, DC 20036-2904 • (202) 737-3600
American Society For Microbiology © 2014   |   Privacy Policy   |   Terms of Use